**Charity number: 1094788** 

## **Pregnancy Sickness Support** 

**Trustees’ annual report and financial statements** 

## **For the year ended 31[st] December 2025** 

**Compass Accountants Venture House The Tanneries East Street Titchfield Hampshire PO14 4AR** 



**PREGNANCY SICKNESS SUPPORT** 

## **Contents** 

||**Page**|
|---|---|
|Legal and administrative information|**1**|
|Chairperson’s statement|**2 - 3**|
|Trustees' annual report|**4 - 5**|
|Statement of Trustees’ responsibilities|**6**|
|Independent Examiner’s Report|**7**|
|Statement of financial activities|**8**|
|Balance sheet|**9**|
|Notes to the financial statements|**10 - 17**|





**PREGNANCY SICKNESS SUPPORT** 

## **Legal and administrative information** 

**Charity number** 1094788 **Principal address** Arena Business Centre 25 Barnes Wallis Road Fareham Hampshire PO15 5TT **Trustees** Dr S Zafar – Chairperson Dr M O’Hara C J Reyner **Accountants** Compass Accountants Limited Venture House The Tanneries East Street Titchfield Hampshire PO14 4AR **Independent examiner** Kerry Lawrance FCA **Bankers** Lloyds Bank PLC 

Lloyds Bank PLC 25 Gresham Street London EC2V 7HN CAF Bank Limited 25 Kings Hill Avenue Kings Hill West Mailing Kent ME19 4JQ 

**Page 1** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Chairperson’s statement for the year ended 31[st] December 2025** 

As Chair of Pregnancy Sickness Support (PSS), I am pleased to present this year's financial report and reflect on another year of significant progress for our charity in 2025. 

Despite a challenging financial environment for charities across the UK, we have remained financially responsible whilst continuing to invest in services for those affected by pregnancy sickness and Hyperemesis Gravidarum (HG), supporting research, education, advocacy and policy influence that make the greatest difference to those living with pregnancy sickness and HG. Every decision made by the Board has been guided by our charitable mission: ensuring that people affected by pregnancy sickness and HG can access effective care, treatment and support, wherever they live in the UK. 

Throughout 2025, we have carefully managed our resources to maximise impact. Income received through grants (including the National Lottery and Boots), fundraising, donations and partnerships has enabled us to continue delivering our core support services while expanding our counselling services for mental health support, healthcare professional education, policy influencing, research collaborations and public awareness. We have also invested in strengthening the charity's long-term sustainability by improving our systems, governance and strategic partnerships. 

In 2025, we worked with MPs and Baroness Merron (Parliamentary Under-Secretary of State at the Department of Health & Social Care) to help rejuvenate the Women's Health Strategy, ensure HG is included within the National Maternity & Neonatal Safety Investigation, and continue campaigning to end the postcode lottery for access to anti-emetic (anti-sickness) medication. Our advocacy focused particularly on improving access to Xonvea so that women across the country can receive appropriate treatment regardless of where they live. This important policy work required direct engagement at Parliamentary level, with PSS's meeting with MPs being featured by ITV News. It represents another landmark in the charity's long history of influencing change. Since PSS was founded in 2002, our advocacy has helped improve awareness and understanding of HG amongst healthcare professionals, the public and Parliament alike. Alongside this work, PSS continued campaigning for Xonvea to be included on all ICB formularies across the UK. 

In early 2025, ITV News featured PSS's work highlighting the mental health impact of HG, with our social media content being viewed over 250,000 times. We launched a petition calling for improved funding for both the physical and mental health treatment of HG, including referral to mental health support services within two weeks of diagnosis. The petition attracted over 11,500 signatures, while our HG Mental Health Campaign raised more than £16,000. 

To support research, PSS announced a partnership with NGM Bio Pharmaceuticals on a clinical trial investigating a potential new drug treatment for HG. To support education, we delivered midwifery training at four universities. During the year, PSS supported 2,441 new helpline contacts, including 104 partners and carers. We trained 867 healthcare professionals, delivered 506 counselling sessions, created 486 peer support matches through our 311 trained volunteers, welcomed 64 participants to our virtual support groups, and saw more than 50,000 people access our website, generating over 7 million social media impressions. 

These figures demonstrate both the scale and depth of our work. For many people living with HG, speaking to someone with lived experience is far more accessible than searching online, particularly when screen use can worsen symptoms. Initial helpline contacts often become the gateway to our wider services, including peer support, counselling (506 counselling sessions) and support groups. Our peer support matches are intensive interventions, typically lasting eight to nine months with multiple contacts each week, while counselling provides specialist support for those experiencing more complex mental health needs. Training healthcare professionals extends our impact far beyond those we directly support, helping improve care for thousands more families. 

**Page 2** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Chairperson’s statement for the year ended 31[st] December 2025** 

To deliver these services, our CEO is supported by a dedicated staff team of seven: Community Engagement Manager, Volunteer Manager, Helpline & Support Manager, Marketing Manager, Helpline Operator, Support & Fundraising Coordinator, and Head of Counselling. Our counselling service is further supported by eight bank counsellors who provide services on an as-needed basis for both self-funded clients and those whose counselling is fully or partially funded by PSS. The CEO is also supported by eight Trustees who make up the Board of Pregnancy Sickness Support. 

In 2025 our unrestricted income was £215,678 and end of December 2025 a healthy balance remained at £268,050. We maintained a healthy flow of fundraising and are grateful to the Lottery Fund that has helped us achieve our goals. 

Our financial decisions are reflected in the impact achieved throughout the year. We supported thousands of individuals and families through our helpline, peer support and counselling services, launched new education programmes for healthcare professionals, strengthened research partnerships and continued to campaign for better recognition and treatment of HG at both a national and Parliamentary level. None of these achievements would have been possible without the generosity of our donors, funders and supporters, and the extraordinary dedication of our volunteers, ambassadors, staff and trustees. 

I would like to extend my sincere thanks to everyone who has supported Pregnancy Sickness Support this year. Whether through fundraising, volunteering, professional expertise, lived experience, corporate partnerships or financial contributions, every person has played a part in helping us improve the lives of families affected by HG. Thank you to our esteemed donors, supporters and valued funders, including the National Lottery, Gallagher, Boots, the Big Give Campaign, and all our incredible fundraisers for your continued trust and support. 

The Board remains committed to ensuring that every pound entrusted to the charity is used wisely and to further our charitable objectives. While we recognise the financial pressures facing the voluntary sector, we are confident that the steps taken this year have strengthened the charity and positioned us well for the future. 

Looking ahead, we will continue to build on this year's achievements by expanding access to support, strengthening our research and policy work, improving healthcare professional education and ensuring that the voices of those affected by HG and pregnancy sickness remain at the heart of everything we do. 

On behalf of the Board of Trustees, thank you for your continued trust and support. 

## _S. Zafar_ 

…………………………………………………………….. Dr S Zafar Chair of Trustees 

Date: 06-08-2026 

**Page 3** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Report of the trustees for the year ended 31[st] December 2025** 

The trustees present their annual report and financial statements for the year ended 31 December 2025. 

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). 

## **Objectives and activities** 

The charity's objects are: 

1. for the advancement of education with regards to sickness in pregnancy, and 

2. to relieve sickness by giving advisory or other services to those who need support due to sickness in pregnancy. 

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake. 

## **Achievements and performance** 

Explanation of the achievements and performance of the charity in the year is detailed in the Chairperson's report. 

## **Financial review** 

Income for the period amounted to £284,140 (2024: £220,126), of which £68,462 (2024: £134,930) was restricted income received in relation to the National Lottery. Charitable expenditure amounted to £289,842 (2024: £323,920), of which £153,898 (2024: £168,914) was restricted expenditure. The majority of the charity’s expenditure continued to be staffing costs, which were £213,898 (2024: £220,471). 

The net movement in funds for the period amounted to a deficit of £5,702 (2024: deficit of £103,794). 

The charity's balance sheet as detailed on page 9 shows a satisfactory position with funds amounting to £276,151 (2024: £281,853). 

## **Reserves policy** 

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month’s expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year. 

At 31 December 2025, the level of free reserves was £275,148 (2024: 194,198), equivalent to 6 months (2024: 6 months) of recurring expenditure. 

The trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks. 

## **Plans for the future** 

Pregnancy Sickness Support (PSS) has outlined several strategic plans to advance its mission of supporting individuals affected by pregnancy sickness and hyperemesis gravidarum (HG). The charity aims to enhance its services by expanding its volunteer network to enable us to offer a diverse background of volunteers for our service users. 

**Page 4** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Report of the trustees for the year ended 31[st] December 2025** 

Additionally, PSS is focused on increasing its research efforts to better understand HG and its impact, partnering with stakeholders outside of the third sector to enable us to better recognise trends, rank treatment and care services in the UK and pre-empt future issues that may arise which will have an impact on our service users. 

PSS will continue to push for standardised care guidelines across all hospital trusts. We are improving the accessibility of our HG Education Program and continuing to do live sessions with top consultants in the field ensuring that individuals with HG receive consistent and high-quality care. 

The charity is also set to enhance its digital presence and community engagement through advanced marketing strategies, increasing awareness and education about HG through different mediums. 

Expanding our mental health support services, to offer a diverse network of counsellors, is another key focus, recognising the significant psychological impact of the condition. 

Furthermore, PSS is committed to strengthening its fundraising efforts to ensure long-term sustainability and the ability to support more individuals. By advocating for policy changes, fostering research collaborations, and bolstering community support, PSS aims to significantly improve the lives of those affected by pregnancy sickness and hyperemesis gravidarum. 

## **Structure, governance and management** 

The charity is controlled by its governing document, a deed of trust registered 27 November 2002, and constitutes an unincorporated charity. 

The trustees who served during the year and up to the date of signature of the financial statements are shown on page 1. 

There shall be at least three trustees. Future trustees shall be appointed by resolution of the trustees passed at a special meeting. 

In selecting persons to be appointed as trustees, the trustees shall take into account the benefits of appointing a person who is able by virtue of their personal or professional qualifications to make a contribution to the pursuits of the objects or management of the charity. 

The charity adopts The Governance Code and utilises the Code to ensure that it stays up to date with compliance, legal framework and relevant legislation. 

**Page 5** 



**PREGNANCY SICKNESS SUPPORT** 

## **Statement of trustees’ responsibilities for the year ended 31[st] December 2025** 

The Trustees are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

Charity law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing these financial statements, the Trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP FRS 102 (2019); 

- make judgements and estimates that are reasonable and prudent; 

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation. 

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

## _S. Zafar_ 

…………………………………………………………….. Dr S Zafar Chair of Trustees 

Date: 06-08-2026 

**Page 6** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Independent Examiner’s Report to the Trustees of Pregnancy Sickness Support** 

I report to the charity trustees on my examination of the accounts of the charity for the year ended 31st December 2025 which are set out on pages 8 to 17. 

## **Responsibilities and basis of report** 

As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’). 

I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

## **Independent examiner’s statement** 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. accounting records were not kept in respect of the charity as required by section 130 of the Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 


….……………………….. Kerry Lawrance FCA 

Date: 7[th] August 2026 

Compass Accountants Limited Venture House, The Tanneries East Street, Titchfield, Hants. PO14 4AR 

**Page 7** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Statement of financial activities (incorporating the income and expenditure account)** 

## **For the year ended 31[st] December 2025** 

|**Unrestricted Restricted**<br>**funds**<br>**funds**<br>**Notes**<br>**£**<br>**£**<br>**Income from:**<br>Donations and Legacies<br>3<br>211,101<br>68,462<br>Investment income<br>4<br>4,577<br>-<br>**Total income**<br>215,678<br>68,462<br>**Expenditure on:**<br>Raising funds<br>5<br>21,365<br>-<br>Charitable activities<br>6<br>114,579<br>153,898<br>**Total expenditure**<br>135,944<br>153,898<br>**Net income/(expenditure)**<br>79,734<br>(85,436)<br>Transfer between funds<br>-<br>-<br>**Net movement in funds**<br>79,734<br>(85,436)<br>**Reconciliation of funds:**<br>Total funds brought forward<br>196,417<br>85,436<br>**Total funds carried forward**<br>276,151<br>-|**2025**<br>**Unrestricted**<br>**Total**<br>**funds**<br>**£**<br>**£**<br>279,563<br>80,864<br>4,577<br>4,332<br>284,140<br>85,196<br>21,365<br>21,768<br>268,477<br>133,238<br>289,842<br>155,006<br>240<br>(69,810)<br>-<br>-<br>(5,702 )<br>(69,810)<br>281,853<br>266,227<br>276,151<br>196,417|**Restricted**<br>**funds**<br>**£**<br>134,930<br>-<br>134,930<br>-<br>168,914<br>168,914<br>(33,984)<br>-<br>(33,984)<br>119,420<br>85,436|**2024**<br>**Total**<br>**£**<br>215,794<br>4,332<br>220,126<br>21,768<br>302,152<br>323,920<br> <br>(103,794)<br>-<br> <br>(103,794)<br>385,647<br>281,853|
|---|---|---|---|



The statement of financial activities includes all gains and losses recognised in the year. 

All income and expenditure derive from continuing activities. 

**The notes on pages 8 to 18 form an integral part of these financial statements** 

**Page 8** 



## **PREGNANCY SICKNESS SUPPORT** 

## **Balance Sheet** 

## **As at 31st December 2025** 

|**Notes**<br>**Fixed assets**<br>Tangible assets<br>11<br>**Current assets**<br>Debtors<br>12<br>Cash at bank and in hand<br>**Creditors: amounts falling**<br>**due within one year**<br>13<br>**Net current assets**<br>**Total assets less current liabilities**<br>**Funds**<br>15<br>Restricted funds<br>16<br>Unrestricted funds<br>**Total funds**|**£**<br>1,233<br>282,267<br>283,500<br>(8,352)|**2025**<br>**£**<br>1,003<br>1,003<br>275,148<br>276,151<br>-<br>276,151<br>276,151|**£**<br>1,316<br>284,614<br>285,930<br>(6,296)|**2024**<br>**£**<br>2,219|
|---|---|---|---|---|
|||||2,219<br>279,634|
|||||281,853|
|||||85,436<br>196,417|
|||||281,853|



The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by 

## **Dr S Zafar Chair of Trustees** 

## **Date: 06-08-2026** 

**The notes on pages 8 to 18 form an integral part of these financial statements** 

**Page 9** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements for the year ended 31[st] December 2025** 

## **1 Accounting policies** 

## **1.1. Charity information** 

Pregnancy Sickness Support is an unincorporated charity, governed by trust deed dated 27 November 2002. The principle office address is 25 Barnes Wallis Road, Fareham, Hampshire, PO15 5TT. 

The principal objectives of the charity are detailed in the Trustees report. 

## **1.2. Basis of accounting** 

The financial statements have been prepared in accordance with the charity’s governing document, the Charites Act 2011, the Charities and Trustee Investment (Scotland) Act 2005, The Charites Accounts (Scotland) Regulations 2006 (as amended), FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charies SORP “Accounting and reporting by charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (effective 1 January 209). The charity is a Public Benefit Entity as defined in FRS 102. 

The financial statements are presented in sterling which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. 

Financial statements have been prepared under the historical cost convention. The principle accounting policies adopted are set out below. 

## **1.3. Going concern** 

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements. 

## **1.4. Charitable funds** 

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives. 

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. 

## **1.5. Incoming resources** 

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. 

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds on covenant is recognised at the time of donation. 

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is unknown, the legacy is treated as a contingent asset. 

Investment income is recognised once received. 

## **1.6. Resources expended** 

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the obligation can be measured reliably. 

**Page 10** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements** 

## **for the year ended 31[st] December 2025** 

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the assets use. 

## **1.7. Tangible fixed assets and depreciation** 

Tangible fixed assets with a cost or value greater than £100 and a useful life exceeding one year are stated at cost less accumulated depreciation. Depreciation is provided at rates calculated to write off the cost less residual value of each asset over its expected useful life, as follows: 

Fixtures and fittings - 25% straight line Computer equipment - 25% straight line 

## **1.8. Impairment of fixed assets** 

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication of those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). 

## **1.9. Cash and cash equivalents** 

Cash and cash equivalents include cash in hand and deposits held at call with banks, other short term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

## **1.10. Financial Instruments** 

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS102 to all of its financial instruments. 

Financial instruments are recognised in the charities balance sheet when the charity becomes party to the contractual provisions of the instrument. 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 

## _**Basic financial assets**_ 

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried out at amortised cost using effective interest methos unless the arrangement constitutes a financial transaction, where the transaction is measured at the present value of the future receipts discounted at the market rate of interest. Financial assets classified as receivable within one year are not amortised. 

## _**Basic financial liabilities**_ 

Borrowings consist wholly of public benefit concessionary loan. Public benefit concessionary loans are loans received between a public benefit entity and another party at below the prevailing market rate of interest and that rate not repayable on demand are for the purposes of furthering the objectives of the public benefit entity. The accounting treatment of concessionary loans is to initially measure these arrangements at the amount received or paid and recognise them in the statement of financial position. Subsequent years, the carrying amount of concessionary loans in the financial statements shall be adjusted to reflect any accrued interest payable or receivable. 

## _**Derecognition of financial liabilities**_ 

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled. 

**Page 11** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements for the year ended 31[st] December 2025** 

## **2. Critical accounting estimates and judgements** 

In the application of the Charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. 

## _**Key sources of estimation uncertainty**_ 

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows: 

## _**Estimated useful lives of tangible fixed assets**_ 

In determining the estimated useful life the charity considers the expected physical wear and tear of the asset that could lead to obsolescence of the asset. Each year the charity reviews the above to establish if there is any change in the expected useful life of tangible assets. 

## **3. Donations** 

|**Donations**||||
|---|---|---|---|
|**Unrestricted**<br>**funds**<br>**£**<br>Donations and Gifts<br>195,101<br>Grants from other charities<br>16,000<br>211,101|**Restricted**<br>**funds**<br>**£**<br>-<br>68,462<br>68,462|**2025**<br>**Total**<br>**£**<br>195,101<br>84,462<br>279,563|**2024**<br>**Total**<br>**£**<br>52,387<br>163,407|
||||215,794|



For the year ended 31[st] December 2024 the Charity received restricted donations of £134,930 and unrestricted donations of £80,864. 

## **4. Investment income** 

|**Investment income**|||||
|---|---|---|---|---|
||**Unrestricted**|**2025**|**Unrestricted**|**2024**|
||**funds**|**Total**|**funds**|**Total**|
||**£**|**£**|**£**|**£**|
|Interest receivable|4,577|4,577|4,332|4,332|



## **5.      Raising funds** 

|**Raising funds**|||
|---|---|---|
|**Unrestricted**<br>**funds**<br>**£**<br>**_Fundraising and publicity_**<br>Other fundraising costs<br>3,184<br>Support costs<br>18,181<br>21,365|**2025**<br>**Unrestricted**<br>**Total**<br>**funds**<br>**£**<br>**£**<br>3,184<br>3,028<br>18,181<br>18,740<br>21,365<br>21,768|**2024**<br>**Total**<br>**£**<br>3,028<br>18,740|
|||21,768|



**Page 12** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements** 

## **for the year ended 31[st] December 2025** 

## **6. Charitable activities** 

|**Unrestricted Restricted**<br>**2025 UnrestrictedRestricted**<br>**funds**<br>**funds**<br>**Total**<br>**funds**<br>**funds**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£ **<br>Share of support costs<br>41,869<br>153,848<br>195,717<br>44,541<br>157,190<br>Share of governance costs<br>72,710<br>50<br>72,760<br>88,697<br>11,724<br>114,579<br>153,898<br>268,477<br>133,238<br>168,914<br>**Governance and support costs**<br>**Fundraising Charitable**<br>**2025**<br>**Fundraising**<br>**Charitable**<br>**activities**<br>**Total**<br>**activities**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**Support costs**<br>Staff costs<br>18,181<br>195,717<br>213,898<br>18,740<br>201,731<br>**Governance costs**<br>Depreciation<br>-<br>1,216<br>1,216<br>-<br>1,686<br>Independent examiners fee<br>-<br>1,200<br>1,200<br>-<br>1,200<br>Accountancy<br>-<br>2,222<br>2,222<br>-<br>2,254 <br>Legal and professional<br>-<br>5,153<br>5,153<br>-<br>12,198<br>Marketing and publicity<br>-<br>14,431<br>14,431<br>-<br>10,088 <br>Other governance costs<br>-<br>48,538<br>48,538<br>-<br>72,995<br>18,181<br>268,477<br>286,658<br>18,740<br>302,152||**2024**<br>**Total**<br>**£**<br>201,731<br>100,421|
|---|---|---|
|||302,152|
|||**2024**<br>**Total**<br>**£**<br>220,471<br>1,686<br>1,200<br>2,254<br>12,198<br>10,088<br>72,995|
|||320,892|



## **7. Governance and support costs** 

## **8. Net incoming resources for the year** 

|**Net incoming resources for the year**|||
|---|---|---|
||**2025**|**2024**|
||**£**|**£**|
|Net incoming resources is stated after charging:|||
|Depreciation and other amounts written off tangible fixed assets|1,216|1,686|
|Auditors' remuneration|1,200|1,200|
|Auditors' remuneration from non-audit work|2,222|2,254|



## **9. Employees** 

|**Employment costs**<br>Wages and salaries<br>Social security costs<br>Other Pension costs|**2025**<br>**£**<br>199,074<br>11,204<br>3,620<br>213,898|**2024**<br>**£**<br>204,350<br>12,393<br>3,728|
|---|---|---|
|||220,471|



No employees received emoluments in the band of £60,000 - £70,000 (2024: One). 

Key management personnel remuneration was as follows: 

Aggregate compensation in the year was £70,308 (2024: £68,346) 

**Page 13** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements** 

## **for the year ended 31[st] December 2025** 

## **Number of employees** 

The average monthly numbers of employees during the year was as follows: 

|**2025**|**2024**|
|---|---|
|**Number**|**Number**|
|8|9|



No trustees (or any person connected with them) received remuneration or benefits during the year or were reimbursed for any expenditure. 

## **10. Taxation** 

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. 

|**11.**<br>**Tangible fixed assets**<br>**Fixtures and**<br>**Computer**<br>**fittings**<br>**Equipment**<br>**£**<br>**£**<br>**Cost**<br>At 1stJanuary 2025<br>1,436<br>6,369<br>Additions<br>-<br>-<br>Disposals<br>-<br>-<br>At 31stDecember 2025<br>1,436<br>6,369<br>**Depreciation**<br>At 1stJanuary 2025<br>1,369<br>4,217<br>Charge for the year<br>67<br>1,149<br>Eliminated in respect of disposals<br>-<br>-<br>At 31stDecember 2025<br>1,436<br>5,366<br>**Net book values**<br>At 31stDecember 2025<br>-<br>1,003<br>At 31stDecember 2024<br>67<br>2,152|**Total**<br>**£**<br>7,805<br>-<br>-|
|---|---|
||7,805|
||5,586<br>1,216<br>-|
||6,802|
||1,003|
||2,219|



All tangible fixed assets are held and used for direct charitable purposes. 

## **12. Debtors** 

|**Debtors**|||
|---|---|---|
|Trade Debtors<br>Prepayments and accrued income|**2025**<br>**£**<br>431<br>802<br>1,233|**2024**<br>**£**<br>430<br>886|
|||1,316|



**Page 14** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements** 

## **for the year ended 31[st] December 2025** 

## **13.       Creditors: amounts falling due within one year** 

|**Creditors: amounts falling due within one year**|||
|---|---|---|
|Other taxes and social security<br>Trade creditors<br>Accruals and deferred income<br>Other creditors|**2025**<br>**£**<br>4,923<br>237<br>2,390<br>802<br>8,352|**2024**<br>**£**<br>3,956<br>-<br>2,340<br>-|
|||6,296|



## **14.      Retirement benefit schemes** 

## **Defined contribution schemes** 

The charity operates a defined contribution scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund. 

The charge to the profit or loss in respect of defined contribution schemes was £3,620 (2024: £3,728). 

## **15. Analysis of net assets between funds** 

|Fund balances at 31 December 2025 as represented by:<br>Tangible fixed assets<br>Current assets/(liabilities)<br>Fund balances at 31 December 2024 as represented by:<br>Tangible fixed assets<br>Current assets/(liabilities)|**Unrestricted Restricted**<br>**funds**<br>**funds**<br>**£**<br>**£**<br>1,003<br>-<br>275,148<br>-<br>276,151<br>-<br>**Unrestricted Restricted**<br>**Funds**<br>**funds**<br>**£**<br>**£**<br>2,219<br>-<br>194,198<br>85,436<br>196,417<br>85,436|**Total**<br>**funds**<br>**£**<br>1,003<br>275,148|
|---|---|---|
|||276,151|
|||**Total**<br>**funds**<br>**£**<br>2,219<br>279,634|
|||281,853|



**Page 15** 



**PREGANCY SICKNESS SUPPORT** 

## **Notes to the financial statements** 

## **for the year ended 31[st] December 2025** 

## **16.       Restricted funds** 

The restricted funds of the charity comprise of the unexpected balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used. 

|**At 1 January**<br>**2025**<br>**r**<br>**£**<br>The National Lottery Community Fund – RC England Wide<br>15,635<br>Office manager fund<br>50,730<br>Upgrading the PSS Peer Support Network<br>8,151<br>Improving the mental health of HG Sufferers<br>3,234<br>Improving treatment pathways for women with HG<br>7,686<br>85,436<br>**At 1 January**<br>**2024**<br>**r**<br>**£**<br>The National Lottery Community Fund – RC England Wide<br>-<br>Office manager fund<br>77,275<br>Upgrading the PSS Peer Support Network<br>9,201<br>Improving the mental health of HG Sufferers<br>15,400<br>Improving treatment pathways for women with HG<br>17,544<br>119,420|**Incoming**<br>**Outgoing**<br>**At 31 December**<br>**esources**<br>**resources**<br>**2025**<br>**£**<br>**£**<br>**£**<br>68,462 <br>(84,097)<br>-<br>- <br>(50,730)<br>-<br>- <br>(8,151)<br>-<br>- <br>(3,234)<br>-<br>- <br>(7,686)<br>-<br>68,462<br>(153,898)<br>-<br>**Incoming**<br>**Outgoing**<br>**At 31 December**<br>**esources**<br>**resources**<br>**2024**<br>**£**<br>**£**<br>**£**<br>134,930  (119,295)<br>15,635<br>- <br>(26,545)<br>50,730<br>- <br>(1,050)<br>8,151<br>- <br>(12,166)<br>3,234<br>- <br>(9,858)<br>7,686<br>134,930<br>(168,914)<br>85,436|**Incoming**<br>**Outgoing**<br>**At 31 December**<br>**esources**<br>**resources**<br>**2025**<br>**£**<br>**£**<br>**£**<br>68,462 <br>(84,097)<br>-<br>- <br>(50,730)<br>-<br>- <br>(8,151)<br>-<br>- <br>(3,234)<br>-<br>- <br>(7,686)<br>-<br>68,462<br>(153,898)<br>-<br>**Incoming**<br>**Outgoing**<br>**At 31 December**<br>**esources**<br>**resources**<br>**2024**<br>**£**<br>**£**<br>**£**<br>134,930  (119,295)<br>15,635<br>- <br>(26,545)<br>50,730<br>- <br>(1,050)<br>8,151<br>- <br>(12,166)<br>3,234<br>- <br>(9,858)<br>7,686<br>134,930<br>(168,914)<br>85,436|
|---|---|---|
|||85,436|



## **Purposes of restricted funds** 

The National Lottery Community Fund – The project aims to improve mental health and physical wellbeing of those whose pregnancies are complicated by severe pregnancy sickness and HG. Increasing capacity for information and support provision will directly benefit 10,500 individuals across England enabling them to come to terms with their own experience of the condition and rebuild their self-confidence thereby reducing their social isolation. Volunteers will benefit through a sense of belonging to the HG community, validation of their personal journey with HG, and further opportunities to increase skill sets which may help career development. 

Office manager fund – Donation to recruit an office/operations manager and pay for one year’s salary. 

Upgrading the PSS Peer Support Network – Pregnancy sickness support are aiming to raise funds to expand and enrich our peer support network, enabling us to provide much needed support to more women and people affected by Nausea and Vomiting in pregnancy (NVP) and the severe form of the condition, Hyperemesis Gravadrium (HG). 

Improving the mental health of HG sufferers – Hyperemesis Gravidarum (HG) is a debilitating and isolating condition which has a detrimental impact on the sufferer’s mental health. Pregnancy Sickness Support are raising vital funds to be able to provide accessible services to improve the sufferers mental health (MH) during pregnancy and beyond. 

Improving treatment pathways for women with HG – 1-3% of all pregnancies are Hyperemesis Gravidarum (HG) pregnancies. So why are seriously ill women still being told by medical professionals to try eating ginger rather than providing safe and effective treatment options? We are raising fund to improve knowledge of healthcare professionals. 

## **18.       Related Party Transactions** 

During the year the charity received no donations from any Trustees (2024: £Nil). 

**Page 16** 

